Photo by nci from unsplash
Persons with haemophilia A (PwHA) with inhibitors to factor VIII often experience decreased health‐related outcomes. In HAVEN 1 (NCT02622321), there was a statistically significant reduction in bleeding with emicizumab prophylaxis… Click to show full abstract
Persons with haemophilia A (PwHA) with inhibitors to factor VIII often experience decreased health‐related outcomes. In HAVEN 1 (NCT02622321), there was a statistically significant reduction in bleeding with emicizumab prophylaxis versus no prophylaxis.
Keywords:
related outcomes;
health related;
emicizumab prophylaxis;
persons haemophilia
Journal Title: Haemophilia
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Haemophilia
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!